<VariationArchive VariationID="619997" VariationName="NM_000834.5(GRIN2B):c.2560del (p.Cys854fs)" VariationType="Deletion" Accession="VCV000619997" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2019-03-19" MostRecentSubmission="2019-03-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="611410" VariationID="619997">
      <GeneList>
        <Gene Symbol="GRIN2B" FullName="glutamate ionotropic receptor NMDA type subunit 2B" GeneID="2904" HGNC_ID="HGNC:4586" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="13537337" stop="13982134" display_start="13537337" display_stop="13982134" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="13714409" stop="14133021" display_start="13714409" display_stop="14133021" Strand="-" />
          </Location>
          <OMIM>138252</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000834.5(GRIN2B):c.2560del (p.Cys854fs)</Name>
      <CanonicalSPDI>NC_000012.12:13567062:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="13567063" stop="13567063" display_start="13567063" display_stop="13567063" variantLength="1" positionVCF="13567062" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="13719997" stop="13719997" display_start="13719997" display_stop="13719997" variantLength="1" positionVCF="13719996" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>C854fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.13719997del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.13719997del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.13567063del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.13567063del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031854.2" sequenceAccession="NG_031854" sequenceVersion="2" change="g.419950del">
            <Expression>NG_031854.2:g.419950del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000834.5" sequenceAccession="NM_000834" sequenceVersion="5" change="c.2560del" MANESelect="true">
            <Expression>NM_000834.5:c.2560del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000825.2" sequenceAccession="NP_000825" sequenceVersion="2" change="p.Cys854fs">
            <Expression>NP_000825.2:p.Cys854fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000834.5(GRIN2B):c.2560del (p.Cys854fs) AND multiple conditions" Accession="RCV000760198" Version="2">
        <ClassifiedConditionList TraitSetID="21888">
          <ClassifiedCondition DB="MedGen" ID="C4015316">Developmental and epileptic encephalopathy, 27</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3151411">Intellectual disability, autosomal dominant 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-03-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-03-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-03-19" MostRecentSubmission="2019-03-19">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="21888" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32574" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 27</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 27</ElementValue>
                <XRef ID="MONDO:0014505" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE27</ElementValue>
                <XRef Type="MIM" ID="616139" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16063" />
                <XRef ID="16063" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delay / intellectual disability (DD/ID) in all affected individuals. Muscle tone abnormalities (spasticity and/or hypotonia, occasionally associated with feeding difficulties), as well as epilepsy and autism spectrum disorder (ASD) / behavioral issues, are common. Other infantile- or childhood-onset findings include microcephaly; dystonic, dyskinetic, or choreiform movement disorder; and/or cortical visual impairment. Brain MRI reveals a malformation of cortical development in a minority of affected individuals. To date, fewer than 100 individuals with GRIN2B-related neurodevelopmental disorder have been reported.</Attribute>
                <XRef ID="NBK501979" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29851452</ID>
                <ID Source="BookShelf">NBK501979</ID>
              </Citation>
              <XRef ID="3451" DB="Orphanet" />
              <XRef ID="C4015316" DB="MedGen" />
              <XRef ID="MONDO:0014505" DB="MONDO" />
              <XRef Type="MIM" ID="616139" DB="OMIM" />
            </Trait>
            <Trait ID="16103" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 6</ElementValue>
                <XRef ID="MONDO:0013509" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES</ElementValue>
                <XRef Type="MIM" ID="613970" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD6</ElementValue>
                <XRef Type="MIM" ID="613970" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12851" />
                <XRef ID="12851" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delay / intellectual disability (DD/ID) in all affected individuals. Muscle tone abnormalities (spasticity and/or hypotonia, occasionally associated with feeding difficulties), as well as epilepsy and autism spectrum disorder (ASD) / behavioral issues, are common. Other infantile- or childhood-onset findings include microcephaly; dystonic, dyskinetic, or choreiform movement disorder; and/or cortical visual impairment. Brain MRI reveals a malformation of cortical development in a minority of affected individuals. To date, fewer than 100 individuals with GRIN2B-related neurodevelopmental disorder have been reported.</Attribute>
                <XRef ID="NBK501979" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29851452</ID>
                <ID Source="BookShelf">NBK501979</ID>
              </Citation>
              <XRef ID="C3151411" DB="MedGen" />
              <XRef ID="MONDO:0013509" DB="MONDO" />
              <XRef Type="MIM" ID="613970" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1741347" SubmissionDate="2018-10-17" DateLastUpdated="2019-03-19" DateCreated="2019-03-19">
        <ClinVarSubmissionID localKey="16A165|OMIM:616139;613970" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000890028" DateUpdated="2019-03-19" DateCreated="2019-03-19" Type="SCV" Version="1" SubmitterName="Génétique des Maladies du Développement, Hospices Civils de Lyon" OrgID="506599" OrganizationCategory="laboratory" OrgAbbreviation="HCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Intellectual Disability NGS Panel (450 genes)</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRIN2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000834.3:c.2560delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616139" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613970" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Lyon_DI-450_20181017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1741347" TraitType="Disease" MappingType="XRef" MappingValue="616139" MappingRef="OMIM">
        <MedGen CUI="C4015316" Name="Developmental and epileptic encephalopathy, 27" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1741347" TraitType="Disease" MappingType="XRef" MappingValue="613970" MappingRef="OMIM">
        <MedGen CUI="C3151411" Name="Intellectual disability, autosomal dominant 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

